Purchases and Sales Made in Q2 2023 in Regulus Therapeutics Inc. (RGLS)
This table provides information about the institutional ownership of Regulus Therapeutics Inc. (RGLS) during Q2 2023. The information is specifically focused on institutions that hold shares of Regulus Therapeutics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Federated Hermes, Inc.
Pittsburgh, PA |
BUY
|
- |
971K+ 33.42% |
$845K - $1.7M
|
3.88M
$6.59M
|
|
|
Aug 14, 2023
Q2 2023
|
Dafna Capital Management LLC
Los Angeles, CA |
BUY
|
- |
555K+ 99.99% |
$483K - $972K
|
1.11M
$1.89M
|
|
|
Aug 14, 2023
Q2 2023
|
Prelude Capital Management, LLC
New York, NY |
BUY
|
- |
40.7KNew |
$35.4K - $71.2K
|
40.7K
$69.1K
|
|
|
Aug 11, 2023
Q2 2023
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
38K+ 51.02% |
$33.1K - $66.6K
|
113K
$191K
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
22K+ 380.56% |
$19.2K - $38.5K
|
27.8K
$47.3K
|
|
|
Aug 11, 2023
Q2 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
7.3K+ 18.81% |
$6.35K - $12.8K
|
46.1K
$78.4K
|
|
|
Jul 31, 2023
Q2 2023
|
Lpl Financial LLC
Fort Mill, SC |
BUY
|
- |
5K+ 37.03% |
$4.35K - $8.75K
|
18.5K
$31.5K
|
|
|
Aug 11, 2023
Q2 2023
|
Ubs Group Ag
|
BUY
|
- |
1.87K+ 107.83% |
$1.63K - $3.28K
|
3.61K
$6.14K
|
|
|
Aug 03, 2023
Q2 2023
|
Barclays PLC
London, X0 |
BUY
|
- |
220+ 4400.0% |
$191 - $385
|
225
$383
|
|
|
Aug 15, 2023
Q2 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
21+ 19.81% |
$18.3 - $36.8
|
127
$216
|
|
|
Aug 14, 2023
Q2 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
8+ 4.04% |
$6.96 - $14
|
206
$350
|
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 14, 2023
Q2 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-4K- 33.83% |
$3.48K - $7K
|
7.83K
$13.3K
|